????????????????? ???????? ?????????? C-Jun N-terminal kinase (JNK) ??? ????????????? ????????
????????? ??????? ?????????? JNK ?? ???????????? ????????? ????????????????????? ??????? ????????????????? ???????? ??? ????????????? ????????????????? ?????????????. ????????? ??? ????????, ????????? ? ????????????????? ?????????? ????????? ??????.
Подобные документы
Immunosuppressive therapy regiments. Analysis of the clinical use of mTOR inhibitors has provided evidence of comparative frequency rate of wound complications and terms of surgical wound healing in the treatment with everolimus and routine therapy.
??????, добавлен 24.02.2016The results of clinical use of mTOR inhibitors, in particular, everolimus, in immunosuppressive therapy regimens. Reasons why immunosuppressive therapy regimens including mTOR inhibitors are preferred in patients with high and moderate risk of graft loss.
??????, добавлен 28.02.2016Risk of development of cardiovascular pathology in patients with terminal renal failure. Study of the features of arterial hypertension, cardiovascular remodeling and plasma level of osteopontin under the influence of candesartan cilexetil therapy.
??????, добавлен 13.01.2017Comprehensive neurotoxic risk assessment of nitrogen-doped multilayer graphene. Analysis of the possibility of interaction with heavy metals in the biological system N-MLG. Use of a Cd2+/Pb2+/Hg2+-induced acute neurotoxicity model in nerve terminals.
??????, добавлен 12.05.2024